Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: Long-term results of two sequential brown university oncology group chemoradiotherapy studies

Annals of Surgical Oncology

Volumn 18, Issue 12, 2011, Pages 3479-3485

  Wanebo, Harold J ^a   Rathore, Ritesh ^b   Chougule, Prakash ^c   Disiena, Michael R ^b   Koness, R James ^b   McRae, Robert G ^d   Nigri, Peter T ^d   Radie Keane, Kathy ^e   Ready, Neal ^f  

^a Landmark Medical Center   (United States)

^b ROGER WILLIAMS MEDICAL CENTER   (United States)

^c Maddock Center for Radiation Oncology   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e North Main Radiation Oncology   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DEHYDRATION; DIARRHEA; DRUG ERUPTION; ESOPHAGITIS; FEMALE; GRAFT FAILURE; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; NECK DISSECTION; NECROSIS; NEUROPATHY; NEUTROPENIA; ORGAN PRESERVATION; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; RADIATION DOSE; RADIATION INJURY; RASH; REPEAT PROCEDURE; SELECTIVE ORGAN PRESERVATION; SIDE EFFECT; SQUAMOUS CELL CARCINOMA; STOMATITIS; TRACHEAL NECROSIS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BIOPSY; WEIGHT REDUCTION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARBOPLATIN; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; GAMMA RAYS; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK DISSECTION; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGAN PRESERVATION; PACLITAXEL; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 83055179746     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1697-0     Document Type: Article

References (30)

1. Salama Jk, Seiwert TY, Vokes EE. Chemoradiotherapy for locally advanced head and neck Cancer. J Clin Oncol. 2007;25:4118-26.
2. Pignon JP, Le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92(1):4-14.
3. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003;349:2091-98.
4. Forastiere AA, Maor M, Weber RS, et al. Long-term results of Intergroup RTOG 91-11: a phase III trial to preserve the larynxinduction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy [abstract]. J Clin Oncol. 2006;24(18 S):5517.
5. Urba SG, Moon J, Giri PG, et al. Organ preservation for advanced resectable cancer of the base of tongue and hypopharynx: a Southwest Oncology Group Trial. J Clin Oncol. 2005;23(1):88-95.
6. Urba S, Wolf G, Eisbruch A, et al. Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol. 2006;24:593-8.
7. Wanebo HJ, Chougule P, Ready N, et al. Preoperative paclitaxel, carboplatin, and radiation therapy in advanced head and neck cancer (stage III and IV). Semin Radiat Oncol. 1999;9(2 Suppl 1):77):77-84.
8. Wanebo HJ, Chougule P, Ready N, et al. Preoperative therapy with reduced dose paclitaxel, and carboplatin and radiation achieves a similar complete response rate to a high dose regimen, but with reduced toxicity [abstract 1655]. Proc Am Soc Clin Oncol. 2000;19.
9. Ready N, Chougule P, Nadeem A, et al. Induction weekly paclitaxel and carboplatin (IT) followed by concurrent paclitaxel, carboplatin and radiotherapy (CRT) in advanced head and neck squamous cell cancers (HN-SCC) [abstract 943]. Proc Am Soc Clin Oncol. 2002;21.
10. Rathore R, Chougule P, Wanebo HJ, et al. Phase I/II study of induction weekly paclitaxel, ifosfamide, and carboplatin (PIC) followed by chemoradiotherapy (CRT) in locally advanced head and neck squamous cell cancer (HNSCC): a Brown University Oncology Group study (HN-86) [abstract 5602]. Proc Am Soc Clin Oncol. 2004;23.
11. Chougule PB, Akhtar MS, Rathore R, et al. Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced inoperable head and neck cancer: five-year follow-up of a Brown University Oncology Group phase II study. Head Neck. 2008;30(3):289-96.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-81.
13. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50(3):163-70.
14. Hoffman HT, Karnell LH, Funk GF, Robinson RA, Menck HR. The National Cancer Database report on cancer of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124(9):951-62.
15. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamouscell carcinoma of the head and neck. N Engl J Med. 2004;350(19):1937-44.
16. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004;350(19):1945-52.
17. Weber RS, Berkey BA, forastiere A, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg. 2003;129:44-49.
18. Adelstein DJ, Lavertu P, Saxton JP, et al. Mature results of a phase III randomized trial comparing concurrent chemoradiotherapy with radiation therapy alone in patients with stage III and IV squamous cell carcinoma of the head and neck. Cancer. 2000;88:876-83.
19. Yom SS, Machtay M, Biel M, et al. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol. 2005;28(4):385-92.
20. Parsons J, Mendenhall W, Stringer S, et al. Squamous cell carcinoma of the oropharynx: surgery, radiation therapy or both. Cancer. 2002;94:2967-80.
21. Al-Othman M, Morris C, Hinerman R, Amdur R, Mendenhall W. Distant metastases after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck. 2003;25:629-33.
22. Liauw SL, Mancuso AA, Amdur RJ, et al. Postradiotherapy neck dissection for lymph node-positive head and neck cancer: The use of computed tomography to manage the neck. J Clin Oncol. 2006;24(9):1421-7.
23. Scher RL, Esclamado RM. Organ and function preservation: the role of surgery as the optimal primary modality or as salvage after chemoradiation failure. Semin Radiat Oncol. 2009;19(1):17-23.
24. Rodel C, Weiss C, Sauer R. Trimodality Treatment and Selective Organ Preservation for Bladder Cancer. J Clin Oncol. 2006;24:5536-44.
25. Wilson KS, Lim JT. Primary chemo-radiotherapy and selective esophagectomy or esophageal cancer: goal of cure with organ preservation. Radiother Oncol. 2000;54(2):129-34.
26. Shipley WU, Kaufman DS, Zehr E, et al. Selective bladder preservation by combined modality protocol treatment: long-term outcomes of 190 patients with invasive bladder cancer. Urology. 2002;60(1):62-7.
27. Tester W, Porter A, Asbell S, et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys. 1993;25(5):783-90.
28. Shipley WU, Winter KA, Kaufman DS, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol. 1998;16:3576-83.
29. Kaufman DS, Winter KA, Shipley WU, et al. The initial results in muscle-invading bladder cancer of RTOG 95-06: phase I/II trial of transurethral surgery plus radiation therapy with concurrent cisplatin and 5-fluorouracil followed by selective bladder preservation or cystectomy depending on the initial response. Oncologist. 2000;5:471-6.
30. Wanebo HJ, Ghebremichael M, Burtness B, et al. Phase II induction cetuximab (C225), paclitaxel (P), and carboplatin (C) followed by chemoradiation with C225, P, C, and RT 68-72 Gy for stage III/IV head and neck squamous cancer: Primary site organ preservation and disease control at 2 years (ECOG, E2303) [abstract 5513]. J Clin Oncol. 2010; (Suppl) 28:15s.